PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AT; United Kingdom. Electronic address: david.baker@qmul.ac.uk.\', \'Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AT; United Kingdom; Pathology Department, VUmc, Amsterdam UMC, Amsterdam, The Netherlands. Electronic address: s.amor@amsterdamumc.nl.\', \'Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AT; United Kingdom; Centre for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.\', \'Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AT; United Kingdom; Clinical Board:Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2211-0348(20)30250-910.1016/j.msard.2020.102174
?:doi
?:hasPublicationType
?:journal
  • Multiple sclerosis and related disorders
is ?:pmid of
?:pmid
?:pmid
  • 32464584
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.123
?:rankingScore_hIndex
  • 18
is ?:relation_isRelatedTo_publication of
?:title
  • The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all